# Comstock Inc.: overview LODE · NYSE · CIK 1120970 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lode.md) · [Financials](/companies/lode/financials.md) · [Filings](/companies/lode/filings.md) · [Insiders](/companies/lode/insiders.md) Latest reported revenue: [$272.8k](/filings/0001437749-26-024304.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 23, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-024304). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [556](/filings/0001437749-25-032230.md) | [1,599 d](/filings/0001437749-26-009589.md) | [786](/filings/0001437749-26-015573.md) | [340](/filings/0001437749-26-024304.md) | [54.1](/filings/0001437749-25-032230.md) | [374 d](/filings/0001437749-26-009589.md) | [313](/filings/0001437749-26-015573.md) | [273](/filings/0001437749-26-024304.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(2447.0%)](/filings/0001437749-25-032230.md) | [(990.6%) d](/filings/0001437749-26-009589.md) | [(895.7%)](/filings/0001437749-26-015573.md) | [(2258.0%)](/filings/0001437749-26-024304.md) | [(18889.3%)](/filings/0001437749-25-032230.md) | [(3533.6%) d](/filings/0001437749-26-009589.md) | [(2853.0%)](/filings/0001437749-26-015573.md) | [(9872.8%)](/filings/0001437749-26-024304.md) | | Net margin | % | [(2690.2%)](/filings/0001437749-25-032230.md) | [(1427.0%) d](/filings/0001437749-26-009589.md) | [(1157.3%)](/filings/0001437749-26-015573.md) | [(2305.1%)](/filings/0001437749-26-024304.md) | [(23832.4%)](/filings/0001437749-25-032230.md) | [(3544.0%) d](/filings/0001437749-26-009589.md) | [(2993.5%)](/filings/0001437749-26-015573.md) | [(9335.1%)](/filings/0001437749-26-024304.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001437749-24-031673.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.9](/filings/0001120970-23-000017.md) | [0.2](/filings/0001120970-24-000014.md) | [1.3](/filings/0001120970-24-000014.md) | [3.0](/filings/0001437749-26-009589.md) | [1.6](/filings/0001437749-26-009589.md) | | Gross margin | % | [68.4%](/filings/0001120970-23-000017.md) | [100.0%](/filings/0001120970-23-000017.md) | not reported | not reported | not reported | | Operating margin | % | [(743.0%)](/filings/0001120970-23-000017.md) | [(10868.0%)](/filings/0001120970-24-000014.md) | [(989.0%)](/filings/0001437749-25-006453.md) | [(1315.1%)](/filings/0001437749-26-009589.md) | [(2455.2%)](/filings/0001437749-26-009589.md) | | Net margin | % | [(2851.4%)](/filings/0001120970-23-000017.md) | [(26235.3%)](/filings/0001120970-24-000014.md) | [718.9%](/filings/0001437749-25-006453.md) | [(1767.9%)](/filings/0001437749-26-009589.md) | [(2772.3%)](/filings/0001437749-26-009589.md) | | Diluted EPS | $ per share | [(0.49)](/filings/0001120970-23-000017.md) | [(0.62)](/filings/0001120970-24-000014.md) | [0.87](/filings/0001437749-25-006453.md) | [(3.21)](/filings/0001437749-26-009589.md) | [(1.17)](/filings/0001437749-26-009589.md) | | Free cash flow | $m | [(7.6)](/filings/0001120970-23-000017.md) | [(13.1)](/filings/0001120970-24-000014.md) | [(15.4)](/filings/0001437749-25-006453.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lode/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $27.8m | 6,693,538 | | Added +408,580 | | [MAK CAPITAL ONE LLC](/funds/1385702.md) | 2026-06-30 | $21.6m | 5,190,177 | | Reduced −573,552 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $17.6m | 4,232,460 | | Added +3,829,970 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.6m | 3,275,091 | | Added +316,134 | | [Northern Right Capital Management, L.P.](/funds/1346543.md) | 2026-06-30 | $9.3m | 2,246,637 | | New +2,246,637 | | [CenterBook Partners LP](/funds/1872738.md) | 2026-06-30 | $9.0m | 2,165,707 | | New +2,165,707 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.9m | 1,904,713 | | Added +1,084,043 | | [GRATIA CAPITAL, LLC](/funds/1599793.md) | 2026-06-30 | $7.8m | 1,868,323 | | Added +761,902 | | [SEI INVESTMENTS CO](/funds/350894.md) | 2026-06-30 | $6.6m | 1,577,910 | | Reduced −122,931 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $6.2m | 1,484,000 | Put | Added +88,000 | ## Recent filings [All 728 filings](/companies/lode/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 23:42 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002812.md) | Ownership report, active investor, amended | 0000921895-26-002812 | | 2026-09-16 | 23:57 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002563.md) | Ownership report, active investor, amended | 0000921895-26-002563 | | 2026-08-24 | 10:30 ET | [8-K](/filings/0001437749-26-028777.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028777 | | 2026-07-24 | 20:16 ET | [8-K](/filings/0001437749-26-024415.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024415 | | 2026-07-23 | 20:06 ET | [10-Q](/filings/0001437749-26-024304.md) | Quarterly report, period 2026-06-30 | 0001437749-26-024304 | | 2026-06-24 | 10:01 ET | [8-K](/filings/0001437749-26-021491.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-021491 | | 2026-06-17 | 21:22 ET | [8-K](/filings/0001437749-26-021003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-021003 | | 2026-06-17 | 10:00 ET | [8-K](/filings/0001437749-26-020855.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020855 | | 2026-06-09 | 10:05 ET | [8-K](/filings/0001437749-26-019911.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-26-019911 | | 2026-06-01 | 20:15 ET | [8-K](/filings/0001437749-26-019042.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-019042 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009589.md), filed Mar 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9d84aaf3-e674-4c82-8be9-af54f2681493) ## About the filer - CIK: 1120970 - Tickers: LODE - Exchange: NYSE - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.